Damlecovatein

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 20:42:06 GMT 2025` Edited by `admin` on `Wed Apr 02 20:42:06 GMT 2025`
Protein Type	FUSION PROTEINS
Protein Sub Type	VIRAL ENVELOPE PROTEIN
Sequence Origin	VIRAL
Sequence Type	COMPLETE
Record UNII	26JP6N8VU6
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Damlecovatein

Official Name

English

319-537-Spike glycoprotein [537-glycine] (severe acute respiratory syndrome coronavirus 2 variant XBB.1.16 precursor) fusion protein with 319-537-spike glycoprotein (severe acute respiratory syndrome coronavirus 2 variant XBB.1.16 precursor)

Preferred Name

English

damlecovatein [INN]

Common Name

English

severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), omicron lineage XBB.1.16 (Gisaid: EPI_ISL_17619088) spike (S) glycoprotein receptor binding domain (RBD) fragment (302-520, 1-219 in the current sequence), variant (K <sup>520</sup> >G <sup>21

Common Name

English

Code System Code Type Description

FDA UNII

26JP6N8VU6

Created by admin on Wed Apr 02 20:42:06 GMT 2025 , Edited by admin on Wed Apr 02 20:42:06 GMT 2025

PRIMARY

CAS

3020658-23-2

Created by admin on Wed Apr 02 20:42:06 GMT 2025 , Edited by admin on Wed Apr 02 20:42:06 GMT 2025

PRIMARY

NCI_THESAURUS

C211718

Created by admin on Wed Apr 02 20:42:06 GMT 2025 , Edited by admin on Wed Apr 02 20:42:06 GMT 2025

PRIMARY

INN

13489

Created by admin on Wed Apr 02 20:42:06 GMT 2025 , Edited by admin on Wed Apr 02 20:42:06 GMT 2025

PRIMARY

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_13
N	1_25
N	1_232
N	1_244

Related Record Type Details


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->VACCINE ANTIGEN

Amount:

Related Record Type Details


					26JP6N8VU6

Damlecovatein

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL